GlassScriptPhysician profile
Diane E Weibeler
NPI 1841769445
$11,716.24
in general payments reported to CMS, 2019-2025
38 companies · $3,107 in 2025
The $3,107 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $1,495 · 2023: $1,661 · 2024: $5,292 · 2025: $3,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,731 · Travel and Lodging: $1,292 · Education: $38.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,730.83 |
| Travel and Lodging | $1,292.01 |
| Education | $38.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,192.80 | 2023-2025 | Indigo System |
| Edwards Lifesciences Corporation | $1,686.89 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $584.81 | 2022-2025 | |
| Amgen INC. | $515.37 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $467.28 | 2023-2025 | Triclip, Mitraclip |
| Pfizer INC. | $452.66 | 2022-2025 | |
| Boston Scientific Corporation | $439.45 | 2021-2024 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $396.14 | 2022-2025 | Farxiga, Wainua, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $362.21 | 2022-2025 | Jardiance |
| Heartflow, INC. | $343.03 | 2024-2025 | |
| Novo Nordisk INC | $297.30 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $269.15 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $247.94 | 2022-2025 | Lifevest |
| Abiomed | $238.45 | 2022-2025 | Impella |
| Impulse Dynamics (USA) INC. | $226.31 | 2022-2023 | Optimizer |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $214.46 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $211.92 | 2022-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $210.39 | 2022-2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $157.80 | 2022-2025 | Amvuttra |
| Inari Medical, INC. | $157.30 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bridgebio Pharma, INC. | $142.05 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $130.70 | 2024 | Arcalyst |
| Csl Behring | $104.88 | 2022-2024 | Kcentra |
| Lexicon Pharmaceuticals, INC. | $102.29 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $87.39 | 2023-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $87.32 | 2022-2023 | Arcalyst |
| Cvrx, INC. | $69.04 | 2023-2025 | Barostim Neo System |
| Shockwave Medical, INC | $48.81 | 2021 | |
| Esperion Therapeutics, INC. | $47.85 | 2023-2025 | Nexletol |
| Glaxosmithkline, LLC. | $41.42 | 2023 | Arexvy, Shingrix |
| Lilly USA, LLC | $31.96 | 2025 | Zepbound, Mounjaro |
| Ionis Pharmaceuticals, INC. | $26.21 | 2025 | Tryngolza |
| Stryker Corporation | $25.74 | 2025 | Flowtriever |
| Bayer Healthcare Pharmaceuticals INC. | $23.80 | 2025 | |
| Cleerly, INC. | $22.15 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic, INC. | $18.00 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $17.87 | 2024 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $17.10 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Weibeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.